Edwards Lifesciences Corp (EW)vsSemler Scientific Inc (SMLR)
EW
Edwards Lifesciences Corp
$82.67
+1.20%
HEALTHCARE · Cap: $48.01B
SMLR
Semler Scientific Inc
$20.33
0.00%
HEALTHCARE · Cap: $348.27M
Smart Verdict
WallStSmart Research — data-driven comparison
Edwards Lifesciences Corp generates 14018% more annual revenue ($6.07B vs $42.98M). SMLR leads profitability with a 86.2% profit margin vs 17.7%. SMLR trades at a lower P/E of 5.0x. EW earns a higher WallStSmart Score of 55/100 (C).
EW
Buy55
out of 100
Grade: C
SMLR
Buy53
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-544.4%
Fair Value
$12.31
Current Price
$82.67
$70.36 premium
Margin of Safety
+90.5%
Fair Value
$213.41
Current Price
$20.33
$193.08 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 23.7%
Attractively priced relative to earnings
Reasonable price relative to book value
Keeps 86 of every $100 in revenue as profit
Earnings expanding 3570.1% YoY
Areas to Watch
Expensive relative to growth rate
Weak financial health signals
Premium valuation, high expectations priced in
Earnings declined 76.6%
Smaller company, higher risk/reward
Revenue declined 43.2%
Negative free cash flow — burning cash
Operating margin of -25.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : EW
The strongest argument for EW centers on Operating Margin. Profitability is solid with margins at 17.7% and operating margin at 23.7%. Revenue growth of 13.3% demonstrates continued momentum.
Bull Case : SMLR
The strongest argument for SMLR centers on P/E Ratio, Price/Book, Profit Margin. Profitability is solid with margins at 86.2% and operating margin at -25.0%.
Bear Case : EW
The primary concerns for EW are PEG Ratio, Piotroski F-Score, P/E Ratio. A P/E of 45.7x leaves little room for execution misses.
Bear Case : SMLR
The primary concerns for SMLR are Market Cap, Revenue Growth, Free Cash Flow.
Key Dynamics to Monitor
EW profiles as a mature stock while SMLR is a declining play — different risk/reward profiles.
SMLR carries more volatility with a beta of 1.33 — expect wider price swings.
EW is growing revenue faster at 13.3% — sustainability is the question.
EW generates stronger free cash flow (354M), providing more financial flexibility.
Bottom Line
EW scores higher overall (55/100 vs 53/100), backed by strong 17.7% margins and 13.3% revenue growth. SMLR offers better value entry with a 90.5% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Edwards Lifesciences Corp
HEALTHCARE · MEDICAL DEVICES · USA
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.
Visit Website →Semler Scientific Inc
HEALTHCARE · MEDICAL DEVICES · USA
Semler Scientific, Inc. develops, manufactures, and markets proprietary products that help healthcare providers evaluate and treat patients with chronic conditions in the United States. The company is headquartered in Santa Clara, California.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?